In a cohort of 115 lung adenocarcinoma patients, expression of CEACAM6 was associated with a five-year disease-free survival rate of 49.1%, as opposed to 74.2% for CEACAM6-negative patients [8]. This evidence concerns the gene CEACAM6 and lung adenocarcinoma.